FindTrial
Sign In

The value of circulating non-coding RNAs as biomarkers in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation

The value of circulating non-coding RNAs as biomarkers in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021341
Enrollment
Unknown
Registered
2019-02-16
Start date
2019-02-15
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Gold Standard:ECG
24-HOUR or 7-DAY Holter
Index test:microRNA
&#32
lncRNA
circRNA

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosed as Atrial fibrillation; 2. refractory to antiarrhythmic drugs (AADs) and Received radiofrequency ablation; 3. voluntarily accept blood withdraw under informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria includes history of valvular heart disease, congenital heart disease, cardiac surgery, thyroid dysfunction, electrolyte disturbance, malignant tumor and immune disease.

Design outcomes

Primary

MeasureTime frame
non-coding RNAs;—

Countries

China

Contacts

Public ContactYang Xinchun

Beijing Chaoyang Hospital, Capital Medical University

yxc6229@sina.com+86 13701186229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026